NYSE · VHT
Financial Services · Asset Management
$320.96
Down-$1.97 (-0.61%)
Updated Aug 29, 2026, 2:00 AM
SID Score
6.8/10
Composite research score
Smart Money
54/100
Neutral
Price performance
1M range · 21 trading sessions · Daily adjusted prices
VHT closed at $320.96 after 21 trading sessions, up 5.30% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $322.84 | $322.84 | $320.285 | $320.96 | 180.57K |
| Aug 27, 2026 | $323.89 | $325.465 | $322.74 | $322.93 | 177.11K |
| Aug 26, 2026 | $327.215 | $328.09 | $325.83 | $326.27 | 279.91K |
| Aug 25, 2026 | $327.40 | $329.85 | $326.64 | $329.01 | 187.06K |
| Aug 24, 2026 | $327.67 | $327.86 | $325.095 | $327.49 | 232.88K |
| Aug 21, 2026 | $323.08 | $329.18 | $322.6909 | $327.70 | 297.66K |
| Aug 20, 2026 | $326.81 | $328.51 | $323.52 | $323.69 | 265.65K |
| Aug 19, 2026 | $323.52 | $330.75 | $323.52 | $329.48 | 276.09K |
| Aug 18, 2026 | $316.48 | $319.97 | $316.34 | $318.84 | 214.87K |
| Aug 17, 2026 | $312.98 | $315.6045 | $312.00 | $314.34 | 151.07K |
| Aug 14, 2026 | $315.04 | $315.23 | $312.66 | $314.70 | 146.36K |
| Aug 13, 2026 | $318.64 | $319.00 | $315.42 | $316.22 | 203.63K |
| Aug 12, 2026 | $313.81 | $317.43 | $312.00 | $316.68 | 129.1K |
| Aug 11, 2026 | $316.10 | $318.85 | $315.265 | $315.71 | 171.92K |
| Aug 10, 2026 | $312.00 | $316.85 | $311.4493 | $316.72 | 206.74K |
| Aug 7, 2026 | $309.28 | $312.22 | $307.09 | $312.12 | 116.92K |
| Aug 6, 2026 | $311.66 | $313.49 | $306.59 | $309.02 | 124.84K |
| Aug 5, 2026 | $307.38 | $310.41 | $305.855 | $308.54 | 222.54K |
| Aug 4, 2026 | $304.57 | $305.2999 | $302.50 | $304.99 | 228.65K |
| Aug 3, 2026 | $305.905 | $308.04 | $303.06 | $304.52 | 294.68K |
| Jul 31, 2026 | $305.38 | $306.08 | $301.51 | $304.81 | 234.83K |
The latest Smart Investors Daily articles mentioning VHT.
VHT research
Company profile and research snapshot.
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). The Advisor attempts to replicate the target index by seeking to invest all, or substantially all, of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.
Consensus and target data currently published for this company.
No generated briefing is available yet.
SeekingAlpha · Jul 25, 2026
Healthcare systems are facing rising operating pressure, thinner margins, and a harder question about how to manage liquidity across the balance sheet as capital needs become more uncertain.
SeekingAlpha · Jul 18, 2026
XLV may offer storm shelter as tech weakens, but valuations look rich and upside may be limited this cycle. Click here to read more.
Benzinga · May 1, 2026
AI‑powered drug discovery, strong earnings upgrades, and rising institutional flows show why healthcare may shift from 2026 laggard to breakout S&P 500 growth story.
SeekingAlpha · Apr 11, 2026
After a 50%+ run from lows last April through highs in mid-January, the Biotech group has been trending sideways over the last few months. Read more here.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning VHT.
